CA2156924A1 - Agents de reticulation a base de polyamides non immunogene hydrosoluble - Google Patents
Agents de reticulation a base de polyamides non immunogene hydrosolubleInfo
- Publication number
- CA2156924A1 CA2156924A1 CA 2156924 CA2156924A CA2156924A1 CA 2156924 A1 CA2156924 A1 CA 2156924A1 CA 2156924 CA2156924 CA 2156924 CA 2156924 A CA2156924 A CA 2156924A CA 2156924 A1 CA2156924 A1 CA 2156924A1
- Authority
- CA
- Canada
- Prior art keywords
- polyamide
- group
- soluble
- water
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
- C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
- Polyamides (AREA)
Abstract
La présente invention concerne des agents de réticulation à base de polyamides non immunogène hydrosoluble et leur emploi pour réticuler, polymériser, décorer et conjuguer des protéines, des polynucléotides et autres substrats biologiques afin de constituer des produits hydrosolubles non immunogènes. La présente invention concerne des protéines, des polynucléotides et autres substrats biologiques qu'il est possible de réticuler, conjuguer, polymériser ou décorer au moyen de polyamides hydrosolubles, pour constituer des produits essentiellement non immunogènes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17388293A | 1993-12-27 | 1993-12-27 | |
US08/173,882 | 1993-12-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2156924A1 true CA2156924A1 (fr) | 1995-07-06 |
Family
ID=22633907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2156924 Abandoned CA2156924A1 (fr) | 1993-12-27 | 1994-12-20 | Agents de reticulation a base de polyamides non immunogene hydrosoluble |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0702553A1 (fr) |
JP (1) | JPH08507549A (fr) |
AU (1) | AU1444095A (fr) |
CA (1) | CA2156924A1 (fr) |
WO (1) | WO1995017886A1 (fr) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1400551B1 (fr) * | 1998-08-28 | 2007-06-13 | Amylin Pharmaceuticals, Inc. | Procédé de fabrication de chaines polyamides de longueur définie et leur conjugués avec des protéines |
AU764144B2 (en) | 1998-08-28 | 2003-08-14 | Gryphon Therapeutics, Inc. | Polyamide chains of precise length, methods to manufacture them and their conjugates |
WO2011034605A2 (fr) | 2009-09-16 | 2011-03-24 | Genentech, Inc. | Complexes protéiques contenant une super-hélice et/ou une attache et leurs utilisations |
AR080793A1 (es) | 2010-03-26 | 2012-05-09 | Roche Glycart Ag | Anticuerpos biespecificos |
WO2012085111A1 (fr) | 2010-12-23 | 2012-06-28 | F. Hoffmann-La Roche Ag | Complexe polypeptide-polynucléotide et son utilisation dans l'administration d'une fraction effectrice ciblée |
BR112013032235A2 (pt) | 2011-06-15 | 2016-11-22 | Hoffmann La Roche | anticorpos do receptor de epo anti-humano e métodos de uso |
RU2644341C2 (ru) | 2012-02-10 | 2018-02-08 | Дженентек, Инк. | Одноцепочечные антитела и другие гетеромультимеры |
CA2871882A1 (fr) | 2012-06-27 | 2014-01-03 | F. Hoffmann-La Roche Ag | Methode de fabrication de conjugues d'anticorps a region fc comprenant au moins une entite de liaison qui se lie specifiquement a une cible et leurs utilisations |
EP2867253B1 (fr) | 2012-06-27 | 2016-09-14 | F. Hoffmann-La Roche AG | Méthode de sélection et de production d'entités de ciblage personnalisées fortement sélectives et multi-spécifiques renfermant au moins deux entités de liaison différentes et leurs utilisations |
JP6445429B2 (ja) | 2012-06-27 | 2018-12-26 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 少なくとも2つの異なる標的化実体を含むテーラーメイドで選択的かつ多重特異性治療用分子を選択および作製するための方法およびその使用 |
SI3151921T1 (sl) | 2014-06-06 | 2019-12-31 | Bristol-Myers Squibb Company | Protitelesa proti z glukortikoidom induciranim receptorjem za faktor nekroze tumorja(GITR) in njihova uporaba |
HUE050596T2 (hu) | 2014-11-21 | 2020-12-28 | Bristol Myers Squibb Co | Antitestek CD73 ellen és azok felhasználásai |
EP3224277B1 (fr) | 2014-11-25 | 2020-08-26 | Bristol-Myers Squibb Company | Nouveaux polypeptides fixant pd-l1 pour l'imagerie |
CN107001482B (zh) | 2014-12-03 | 2021-06-15 | 豪夫迈·罗氏有限公司 | 多特异性抗体 |
JP6738348B2 (ja) | 2014-12-19 | 2020-08-12 | リジェネサンス ベスローテン フェンノートシャップ | ヒトc6に結合する抗体およびその使用 |
WO2016127052A1 (fr) | 2015-02-05 | 2016-08-11 | Bristol-Myers Squibb Company | Cxcl11 et smica comme biomarqueurs prédictifs de l'efficacité de l'immunothérapie anti-ctla-4 |
HRP20230060T1 (hr) | 2015-05-29 | 2023-03-17 | Bristol-Myers Squibb Company | Antitijela protiv ox40 i njihova primjena |
MX2018006072A (es) | 2015-11-19 | 2018-08-01 | Squibb Bristol Myers Co | Anticuerpos contra receptor de factor de necrosis de tumor inducido por glucocorticoides (gitr) y usos de los mismos. |
US20190284293A1 (en) | 2016-03-04 | 2019-09-19 | Bristol-Myers Squibb Company | Combination therapy with anti-cd73 antibodies |
KR102397783B1 (ko) | 2016-06-01 | 2022-05-12 | 브리스톨-마이어스 스큅 컴퍼니 | Pd-l1 결합 폴리펩티드에 의한 pet 영상화 |
TWI780057B (zh) | 2016-07-14 | 2022-10-11 | 美商必治妥美雅史谷比公司 | 針對tim3之抗體及其用途 |
JP7045724B2 (ja) | 2016-11-07 | 2022-04-01 | ニューラクル サイエンス カンパニー リミテッド | 配列類似性を持つ抗ファミリー19、メンバーa5抗体及びその用途 |
SG11201906947SA (en) | 2017-02-17 | 2019-08-27 | Bristol Myers Squibb Co | Antibodies to alpha-synuclein and uses thereof |
WO2019075090A1 (fr) | 2017-10-10 | 2019-04-18 | Tilos Therapeutics, Inc. | Anticorps anti-lap et leurs utilisations |
KR20200108870A (ko) | 2018-01-12 | 2020-09-21 | 브리스톨-마이어스 스큅 컴퍼니 | Tim3에 대한 항체 및 그의 용도 |
MX2020009861A (es) | 2018-03-23 | 2020-10-08 | Bristol Myers Squibb Co | Anticuerpos contra el complejo principal de histocompatibilidad relacionado con las cadenas a y b clase i (mica) y/o (micb) y sus usos. |
MA52190A (fr) | 2018-04-02 | 2021-02-17 | Bristol Myers Squibb Co | Anticorps anti-trem-1 et utilisations associées |
KR102661891B1 (ko) | 2018-05-10 | 2024-05-23 | 주식회사 뉴라클사이언스 | 서열 유사성 19, 멤버 a5 항체를 갖는 항-패밀리 및 그의 사용 방법 |
EP3841124A4 (fr) | 2018-06-29 | 2022-03-23 | ApitBio, Inc. | Anticorps anti-l1cam et leurs utilisations |
EP3863722A2 (fr) | 2018-10-10 | 2021-08-18 | Tilos Theapeutics, Inc. | Variants d'anticorps anti-lap et leurs utilisations |
US20210403602A1 (en) | 2018-12-03 | 2021-12-30 | Bristol-Myers Squibb Company | Anti-ido antibody and uses thereof |
PE20212305A1 (es) | 2019-01-22 | 2021-12-10 | Bristol Myers Squibb Co | Anticuerpos contra subunidad alfa il-7r y usos de estos |
CN114144435B (zh) | 2019-07-15 | 2024-06-25 | 百时美施贵宝公司 | 针对人trem-1的抗体及其用途 |
CN114174536A (zh) | 2019-07-15 | 2022-03-11 | 百时美施贵宝公司 | 抗trem-1抗体及其用途 |
WO2021207449A1 (fr) | 2020-04-09 | 2021-10-14 | Merck Sharp & Dohme Corp. | Anticorps anti-lap à maturation d'affinité et leurs utilisations |
JP2024514530A (ja) | 2021-04-02 | 2024-04-02 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 切断型cdcp1に対する抗体およびその使用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4168602A (en) * | 1975-03-11 | 1979-09-25 | Sun Ventures, Inc. | Block copolymer of poly (dioxaarylamide) and polyamide and fibers and fibrous material produced therefrom |
US5053520A (en) * | 1988-09-22 | 1991-10-01 | Abbott Laboratories | Heterobifunctional maleimido containing coupling agents |
-
1994
- 1994-12-20 AU AU14440/95A patent/AU1444095A/en not_active Abandoned
- 1994-12-20 WO PCT/US1994/014821 patent/WO1995017886A1/fr not_active Application Discontinuation
- 1994-12-20 JP JP7518149A patent/JPH08507549A/ja active Pending
- 1994-12-20 EP EP95906090A patent/EP0702553A1/fr not_active Withdrawn
- 1994-12-20 CA CA 2156924 patent/CA2156924A1/fr not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1995017886A1 (fr) | 1995-07-06 |
EP0702553A4 (fr) | 1996-01-19 |
EP0702553A1 (fr) | 1996-03-27 |
JPH08507549A (ja) | 1996-08-13 |
AU1444095A (en) | 1995-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2156924A1 (fr) | Agents de reticulation a base de polyamides non immunogene hydrosoluble | |
ES2404685T3 (es) | Derivados heterobifuncionales de poli(etilenglicol) y métodos para su preparación | |
AU764144B2 (en) | Polyamide chains of precise length, methods to manufacture them and their conjugates | |
US9169350B2 (en) | N-maleimidyl polymer derivatives | |
Yang et al. | Penicillin V-conjugated PEG-PAMAM star polymers | |
US4745161A (en) | Soluble and biodegradable polyamino acid activated for bonding of biologically active compound | |
US5548064A (en) | Vitamin B12 conjugates with EPO, analogues thereof and pharmaceutical compositions | |
US20020072573A1 (en) | Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation | |
KR860000526B1 (ko) | 아미노-기능이 부여된 아크릴 공중합체의 제조방법 | |
JPH06506217A (ja) | ポリペプチドまたはグリコポリペプチドとポリマーとのヒドラジン含有結合体 | |
JPS6014028B2 (ja) | ヒドロキシ−スクシンイミド−エステル誘導体及びその製造法 | |
US5738864A (en) | Drug delivery agents incorporating mitomycin | |
CN1381512A (zh) | 多臂树杈型功能化聚乙二醇制备方法及它在药物中的应用 | |
Caldwell et al. | Synthesis of water‐soluble polyamidoamines for biomedical applications. II. Polymers possessing intrachain‐type secondary amino groups suitable for side‐chain attachment | |
AU675686B2 (en) | Water soluble non-immunogenic polyamide cross-linking agents | |
JP2003528939A (ja) | 分解性ポリマー | |
Machado et al. | Water‐soluble polyamides as potential drug carriers, V. Carboxy‐functionalized polyaspartamides and copolyaspartamides | |
EP1400551B1 (fr) | Procédé de fabrication de chaines polyamides de longueur définie et leur conjugués avec des protéines | |
KR100551096B1 (ko) | 신규한 와이-폴리에틸렌글리콜 유도체 및 그의 제조방법 | |
Palacios et al. | Novel solid-phase synthesis of thiol-terminated-poly (α-amino acid)-drug conjugate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |